Wikidata

(Q40547967)

English

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis

scientific article published on June 2004

In more languages

Statements

title
Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
author name string
Malucchi S
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
Gilli F
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
Bottero R
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
Di Sapio A
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
Capobianco M
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
Bertolotto A
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
publication date
1 June 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017
page(s)
2031-2037
1 reference
stated in
Europe PubMed Central
PubMed ID
15184610
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40547967&oldid=1900251331"